Stephen Hoge
President · Moderna, Inc. (MRNA)
sold: $28,704,958 · planned sales: $45,604,975
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| November 17, 2026 | Planned sale 10b5-1 plan | 39,215 | — | $8,298,105 | SEC |
| November 16, 2026 | Planned sale 10b5-1 plan | 39,160 | — | $8,601,863 | SEC |
| October 15, 2026 | Planned sale 10b5-1 plan | 39,145 | — | $8,640,033 | SEC |
| October 15, 2026 | Sale 10b5-1 plan | 78,369 | $217.10 | $17,013,538 | SEC |
| October 14, 2026 | Planned sale 10b5-1 plan | 39,224 | — | $8,373,519 | SEC |
| September 15, 2026 | Planned sale 10b5-1 plan | 40,281 | — | $5,883,709 | SEC |
| September 15, 2026 | Sale 10b5-1 plan | 80,575 | $145.10 | $11,691,420 | SEC |
| September 14, 2026 | Planned sale 10b5-1 plan | 40,294 | — | $5,807,746 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
